Larvol Delta - First-in-Human-Study-With-NG641-an-Oncolytic-Transgene-Expressing-Adenoviral-Vector

NG-641 - PsiOxus

http://clinicaltrials.gov/ct2/show/NCT04053283

Nov 15, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next